Cutaneous Leishmaniasis Completed Phase 2 / 3 Trials for Pentoxifylline (DB00806)

Also known as: Leishmaniasis, Cutaneous / Cutaneous leishmaniasis (disorder)

IndicationStatusPhase
DBCOND0028439 (Cutaneous Leishmaniasis)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01464242Add-on Study of Pentoxifylline in Cutaneous LeishmaniasisTreatment
NCT01381055Antimony Plus Pentoxifylline in Cutaneous LeishmaniasisTreatment